Lk.rar 【Top】
Conventional pharmacological approaches often fail to provide sustained glycemic management. Key Agents:
Obese Zucker diabetic fatty (ZDF) rats (a standard model for type 2 diabetes). Groups: Control (Cellulose/Vehicle). NPS (5% wt:wt) + Vehicle. Cellulose + Sitagliptin [10 mg/(kg · d)]. NPS (5%) + Sitagliptin [10 mg/(kg · d)]. LK.rar
Blood glucose levels, satiety hormones, weight gain. 3. Expected Results (Based on study context) LK.rar
To determine if combining NPS (PGX) with sitagliptin reduces hyperglycemia in Zucker diabetic fatty (ZDF) rats better than either treatment alone [17]. 2. Methodology LK.rar
A dipeptidyl peptidase 4 (DPP4) inhibitor that increases glucagon-like peptide-1 (GLP-1) [17].
Conventional pharmacological approaches often fail to provide sustained glycemic management. Key Agents:
Obese Zucker diabetic fatty (ZDF) rats (a standard model for type 2 diabetes). Groups: Control (Cellulose/Vehicle). NPS (5% wt:wt) + Vehicle. Cellulose + Sitagliptin [10 mg/(kg · d)]. NPS (5%) + Sitagliptin [10 mg/(kg · d)].
Blood glucose levels, satiety hormones, weight gain. 3. Expected Results (Based on study context)
To determine if combining NPS (PGX) with sitagliptin reduces hyperglycemia in Zucker diabetic fatty (ZDF) rats better than either treatment alone [17]. 2. Methodology
A dipeptidyl peptidase 4 (DPP4) inhibitor that increases glucagon-like peptide-1 (GLP-1) [17].